Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide

Published on Mar 1, 2011in Journal of Vascular Surgery3.24
· DOI :10.1016/j.jvs.2010.09.038
Kathleen G. Raman9
Estimated H-index: 9
(University of Pittsburgh),
Robin E. Gandley17
Estimated H-index: 17
(University of Pittsburgh)
+ 2 AuthorsEdith Tzeng38
Estimated H-index: 38
(University of Pittsburgh)
Objective Atherosclerosis results in vasomotor dysfunction, in part, through impairment of nitric oxide (NO) dependent vasodilation. It is unclear whether blood vessels are dysfunctional in an early environment of hypercholesterolemia alone and if this contributes to the vascular injury response. We hypothesize that early hypercholesterolemia, prior to gross vascular changes, contributes to vasomotor dysfunction and the vascular injury response. The efficacy of NO therapy to protect against the injury response in this setting was also assessed. Methods The effect of oxidized low density lipoprotein (oxLDL) and inducible NO synthase (iNOS) gene transfer on rat aortic smooth muscle cell (SMC) proliferation was measured with 3 H-thymidine incorporation. Common carotid arteries (CCA) from wild-type C57BL6 (WT or C57) and apolipoprotein E deficient (ApoE KO) mice fed normal or Western diets for 6 to 8 weeks were tested for vasomotor function using an arteriograph system. Studies were repeated after CCA injury. The effect of iNOS gene transfer on morphometry by histology and vasomotor responses in injured CCAs in ApoE KO was examined. Results OxLDL increased SMC proliferation by >50%. In SMC expressing iNOS, NO production was unaffected by oxLDL and reduced oxLDL and still inhibited SMC proliferation. Endothelium dependent vasorelaxation was reduced in uninjured CCAs from ApoE KO and C57 mice on the Western vs normal diet (ApoE 39% ± 2% vs 55% ± 13%; C57 50% ± 13% vs 76% ± 5%, P 2 ; media 46,306 ± 2448 vs 11,714 ± 392 μm 2 , respectively; P Conclusions Early hypercholesterolemia impairs endothelial function, with severity being related to duration and magnitude of hypercholesterolemia. Severe hypercholesterolemia leads to atheromatous lesion formation following injury and stresses the role of vascular injury in atherogenesis and suggests different mechanisms are involved in endothelial dysfunction and the injury response. Despite these changes, iNOS gene transfer still effectively inhibits atheroma formation. These findings support early correction of hypercholesterolemia and emphasize the potential role for NO based therapies in disease states.
  • References (39)
  • Citations (15)
#1Kyomars Abbasi (Tehran University of Medical Sciences)H-Index: 10
#2Maryam Sotudeh Anvari (Tehran University of Medical Sciences)H-Index: 3
Last.Narges Ashrafinia (Tehran University of Medical Sciences)H-Index: 3
view all 9 authors...
3 CitationsSource
#1Beat A. Kaufmann (OHSU: Oregon Health & Science University)H-Index: 19
#2John M. Sanders (UVA: University of Virginia)H-Index: 24
Last.Jonathan R. LindnerH-Index: 69
view all 7 authors...
321 CitationsSource
#1John E. DeanfieldH-Index: 74
#2Julian HalcoxH-Index: 36
Last.Ton J. RabelinkH-Index: 73
view all 3 authors...
1,681 CitationsSource
#1Christian M. MatterH-Index: 44
#2Limming MaH-Index: 1
Last.Thomas F. LüscherH-Index: 123
view all 12 authors...
27 CitationsSource
#1Rolando J. Ramirez (University of Pittsburgh)H-Index: 10
#2Carl A. Hubel (University of Pittsburgh)H-Index: 40
Last.Robin E. Gandley (University of Pittsburgh)H-Index: 17
view all 6 authors...
17 CitationsSource
#2Michael KasperH-Index: 50
Last.Ruth H. StrasserH-Index: 48
view all 8 authors...
5 CitationsSource
6,104 CitationsSource
#1Deling Kong (NKU: Nankai University)H-Index: 43
#2Luis G. Melo (Queen's University)H-Index: 30
Last.Victor J. Dzau (Duke University)H-Index: 117
view all 8 authors...
266 CitationsSource
363 CitationsSource
#1Toshio Hayashi (Nagoya University)H-Index: 41
#2Daigo Sumi (UCLA: University of California, Los Angeles)H-Index: 12
Last.Louis J. Ignarro (UCLA: University of California, Los Angeles)H-Index: 85
view all 11 authors...
51 CitationsSource
Cited By15
#1Thomas Kerforne (University of Poitiers)H-Index: 6
#2Frederic Favreau (University of Limoges)H-Index: 13
Last.Thierry HauetH-Index: 26
view all 10 authors...
#1Peggy Sfyri (Hull York Medical School)H-Index: 2
#2Antonios Matsakas (Hull York Medical School)H-Index: 17
3 CitationsSource
#1Grégory FranckH-Index: 11
#2Thomas MawsonH-Index: 5
Last.Peter LibbyH-Index: 187
view all 17 authors...
26 CitationsSource
#1Grégory FranckH-Index: 11
#2Thomas MawsonH-Index: 5
Last.Peter LibbyH-Index: 187
view all 17 authors...
#1Junya Makino (Gifu Pharmaceutical University)H-Index: 6
#2Rei Asai (Gifu Pharmaceutical University)H-Index: 1
Last.Tetsuo Adachi (Gifu Pharmaceutical University)H-Index: 17
view all 8 authors...
10 CitationsSource
#1Miguel Romero (UCL: Université catholique de Louvain)H-Index: 1
#2Elvira Leon-Gomez (UCL: Université catholique de Louvain)H-Index: 4
Last.Chantal Dessy (UCL: Université catholique de Louvain)H-Index: 38
view all 7 authors...
5 CitationsSource
#1Roxana Oberkersch (UBA: University of Buenos Aires)H-Index: 4
#2Francesca Maccari (University of Modena and Reggio Emilia)H-Index: 19
Last.Graciela C. Calabrese (UBA: University of Buenos Aires)H-Index: 7
view all 6 authors...
8 CitationsSource
#1Asija Zaciragic (University of Sarajevo)H-Index: 10
#2Jasminko Huskić (University of Sarajevo)H-Index: 5
Last.Radivoj Jadrić (University of Sarajevo)H-Index: 4
view all 7 authors...
4 CitationsSource
#1N. Chatauret (University of Poitiers)H-Index: 7
#2Frédéric Favreau (University of Poitiers)H-Index: 9
Last.Thierry Hauet (University of Poitiers)H-Index: 26
view all 8 authors...
4 CitationsSource
#1Luca Alberti (UniSR: Vita-Salute San Raffaele University)H-Index: 3
#2Camilla Torlasco (UniSR: Vita-Salute San Raffaele University)H-Index: 2
Last.Gabriele Fragasso (UniSR: Vita-Salute San Raffaele University)H-Index: 29
view all 9 authors...
10 CitationsSource